Ninety-five participants with DSM-IV borderline personality disorder were randomly assigned to receive @ mg/day of quetiapine ( the low-dosage group ; N = @ ) , @ mg/day of quetiapine ( the moderate-dosage group ; N = @ ) , or placebo ( N = @ ) .